scientific graphic

The Tisch Cancer Institute 2024 Specialty Report

Advancing Clinical Breakthroughs to Prevent and Eradicate Cancer

The mission of The Tisch Cancer Institute is to accelerate the prevention and treatment of cancer, improving the lives of cancer patients and their families in our diverse communities.  As a leading National Cancer Institute-Designated Cancer Center, we leverage a multidisciplinary approach to research and treatment—with the goal of advancing clinical breakthroughs that transform patient care.

Established in 2008, The Tisch Cancer Institute encompasses a distinguished faculty of more than 150 prominent scientists and physicians. Together, we have developed innovative research programs that build upon Mount Sinai Health System’s legacy of biomedical discovery, outstanding patient care, and innovative medical and scientific training. We collaborate across disciplines to advance novel treatments, such as immunotherapy, that offer hope for those living with cancer.

Find A Clinical Trial Make a Gift Discover Careers

MEET THE DIRECTOR

Ramon Parsons, MD, PhD

Ramon Parsons headshot

DIRECTOR, THE TISCH CANCER INSTITUTE

PROFESSOR & CHAIR | Oncological Sciences

PROFESSOR | Medicine, Hematology and Medical Oncology

Ramon E. Parsons, MD, PhD, is Director of The Tisch Cancer Institute (TCI) and Dean for...

AT A GLANCE

Research at The Tisch Cancer Institute

11865
Publications
8801
Press/Media

179 Researchers

Researchers Image 1
Researchers Image 2
Researchers Image 5
Researchers Image 6
View All Researchers

Recent Publications

Total-body skin examination prevalence among individuals with risk factors for skin cancer by insurance type a National Health Interview Survey study. Archives of Dermatological Research

Neonatal Morbidities, Neurodevelopmental Impairments, and Positive Health among Children Surviving Birth before 32 Weeks of Gestation. Journal of Pediatrics

Associations between prenatal exposure to environmental phenols and child neurodevelopment at two years of age in a South African birth cohort. Environmental Research

View Full Details

Our Research Programs

one-on-one meeting Cancer Clinical Investigation
lady writing on dry erase board Cancer Immunology
researchers analyzing speciman Cancer Mechanisms
researcher analyzing sample on a slide Cancer Prevention and Control

Moving the Field Forward

Find out how we collaborate to address cancer’s most complex challenges.

Stuart A. Aaronson, MD: 2024 Jacobi Medallion Recipient
Thomas Marron, MD, PhD – AACR Annual Meeting 2023
Ramon Parsons, MD, PhD: 2023 Jacobi Medallion Recipient
2022 Distinguished Scholar Award - Dr. Alice Kamphorst
Center of Excellence: Liver and Bile Duct Cancer
Tisch Cancer Institute COVID-19 Research Briefing: May 14, 2020
Watch Videos

We Are Shaping Tomorrow

Nina Bhardwaj headshot

Cancer Immunotherapy Pioneer Elected to National Academy of Medicine

Read about Nina Bhardwaj, MD, PhD.

Igor Bado headshot

Uncovering the Link Between Breast Cancer and Bone Metastasis

Read about Igor Bado, PhD.

Karyn Goodman headshot

Envisioning a New Landscape of Treatment for Patients With Disabilities

Discover how we removed a roadblock to treat one cancer patient.

Discover the Latest

Doctor adjusting microscope
2024-12-18 00:00:00.0
Mount Sinai Study Reveals Immune-Modulatory Mechanism of Lurbinectedin in Small-Cell Lung Cancer
Read More
Dubin Gala
2024-12-16 00:00:00.0
Dubin Breast Center Annual Gala at Ziegfeld Ballroom Raises $3.8 Million
Read More
Wagenblast
2024-12-11 00:00:00.0
Mount Sinai’s Elvin Wagenblast Honored by Leukemia & Lymphoma Society for Advancing Research in Childhood Leukemia
Read More
Venetoclax
2024-11-27 00:00:00.0
Mount Sinai Researchers Identify Six-Gene Pattern to Predict Drug Success in Multiple Myeloma Patients
Read More
REsearcher using computer
2024-11-13 00:00:00.0
The Tisch Cancer Institute at Mount Sinai Highlights Key Developments for Lung Cancer Awareness Month 2024
Read More
Bhardwaj
2024-11-06 00:00:00.0
Mount Sinai’s Nina Bhardwaj Elected to National Academy of Medicine for Contributions to Cancer Immunotherapy
Read More
Staten Island
2024-11-04 00:00:00.0
Mount Sinai Health System Expands Care in Staten Island
Read More
Leukemia
2024-10-30 00:00:00.0
Mount Sinai Researchers Uncover Why Some Leukemia Cells May Resist Treatment
Read More
Follow Tisch Cancer Institute

Resources For You

Cancer Centers of Excellence
Patient Care
Oncological Sciences
Hematology and Medical Oncology
Residencies and Fellowships
Shared Resources

Contact Us

The Tisch Cancer Institute

One Gustave L. Levy Place

Box 1128

New York, NY 10029-6574

Christine Ponder, PhD, MPA
Director, Research Administration

212-659-5600
Email

Patient Information
The Clinical Research Support Unit

212-824-7391
Email